Search | TVST | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles January 2019

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost

PDF

Susan S. Lee; Alexandra Almazan; Sherri Decker; Yan Zhong; Alazar N. Ghebremeskel; Patrick Hughes; Michael R. Robinson; James A. Burke; Robert N. Weinreb
TAGS: bimatoprost, intraocular pressure, pharmacokinetics
Trans. Vis. Sci. Tech.. 2019; 8(1):15. https://doi.org/10.1167/tvst.8.1.15

ARVO Annual Meeting Abstract June 2017

Brimonidine drug delivery system (Brimo DDS Generation 1) slows the growth of retinal pigment epithelial hypofluorescence following regional blue light irradiation in a nonhuman primate (NHP) model of geographic atrophy (GA)

Corine Ghosn; Alexandra Almazan; Sherri Decker; James A Burke

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1960.

ARVO Annual Meeting Abstract June 2013

Ocular bioavailability of brimonidine 0.1% BID in non-human primates

Chinatsu Tosha; Sherri Decker; Guadalupe Ruiz; Octavio Avalos; Werhner Orilla; Larry Gruber; Ton Lin; Alexandra Almazan; Daniel Gil; James Burke

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5072.

ARVO Annual Meeting Abstract March 2012

Angle Narrowing with Topical Latanoprost in Normal Dogs

Alexandra S. Almazan; Susan Tsai; Susan S. Lee; Huajiang Li; Paul Conforti; Sherri Decker; James A. Burke; Michael R. Robinson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5029.

ARVO Annual Meeting Abstract April 2011

Chronic Anterior Uveitis and Reduced Corneal Endothelial Cell Density Associated with a Laser-Induced Glaucoma Model

Susan Tsai; Alexandra Almazan; Larry Gruber; Sherri Decker; Michael R. Robinson; Ton Lin; James A. Burke

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2435.

Advertisement